List of Tables:
Table 1. Snapshot of Europe Monoclonal Antibodies Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in Europe Monoclonal Antibodies Market 33
Table 5. Europe Monoclonal Antibodies Market by Source, 2019-2030, $ bn 41
Table 6. Europe Monoclonal Antibodies Market by Category, 2019-2030, $ bn 47
Table 7. Europe Monoclonal Antibodies Market by Production Type, 2019-2030, $ bn 51
Table 8. Europe Monoclonal Antibodies Market by Application, 2019-2030, $ bn 55
Table 9. Europe Monoclonal Antibodies Market: Cancer Therapy by Type, 2019-2030, $ bn 58
Table 10. Europe Monoclonal Antibodies Market by End User, 2019-2030, $ bn 68
Table 11. Europe Monoclonal Antibodies Market by Country, 2019-2030, $ bn 75
Table 12. Germany Monoclonal Antibodies Market by Source, 2019-2030, $ bn 77
Table 13. Germany Monoclonal Antibodies Market by Application, 2019-2030, $ bn 77
Table 14. Germany Monoclonal Antibodies Market by End User, 2019-2030, $ bn 77
Table 15. U.K. Monoclonal Antibodies Market by Source, 2019-2030, $ bn 79
Table 16. U.K. Monoclonal Antibodies Market by Application, 2019-2030, $ bn 79
Table 17. U.K. Monoclonal Antibodies Market by End User, 2019-2030, $ bn 79
Table 18. France Monoclonal Antibodies Market by Source, 2019-2030, $ bn 81
Table 19. France Monoclonal Antibodies Market by Application, 2019-2030, $ bn 81
Table 20. France Monoclonal Antibodies Market by End User, 2019-2030, $ bn 81
Table 21. Spain Monoclonal Antibodies Market by Source, 2019-2030, $ bn 83
Table 22. Spain Monoclonal Antibodies Market by Application, 2019-2030, $ bn 83
Table 23. Spain Monoclonal Antibodies Market by End User, 2019-2030, $ bn 83
Table 24. Italy Monoclonal Antibodies Market by Source, 2019-2030, $ bn 85
Table 25. Italy Monoclonal Antibodies Market by Application, 2019-2030, $ bn 85
Table 26. Italy Monoclonal Antibodies Market by End User, 2019-2030, $ bn 85
Table 27. Russia Monoclonal Antibodies Market by Source, 2019-2030, $ bn 87
Table 28. Russia Monoclonal Antibodies Market by Application, 2019-2030, $ bn 87
Table 29. Russia Monoclonal Antibodies Market by End User, 2019-2030, $ bn 87
Table 30. Monoclonal Antibodies Market in Rest of Europe by Country, 2019-2030, $ bn 89
Table 31. Abbott Laboratories: Company Snapshot 94
Table 32. Abbott Laboratories: Business Segmentation 94
Table 33. Abbott Laboratories: Product Portfolio 95
Table 34. Abbott Laboratories: Revenue, 2018-2020, $ bn 95
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. Europe Monoclonal Antibodies Market, 2019-2030, $ bn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Europe Monoclonal Antibodies Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 9. Primary Restraints and Impact Factors of Europe Monoclonal Antibodies Market 30
Figure 10. Investment Opportunity Analysis 34
Figure 11. Porters Fiver Forces Analysis of Europe Monoclonal Antibodies Market 37
Figure 12. Breakdown of Europe Monoclonal Antibodies Market by Source, 2019-2030, % of Revenue 42
Figure 13. Europe Addressable Market Cap in 2021-2030 by Source, Value ($ bn) and Share (%) 42
Figure 14. Europe Monoclonal Antibodies Market by Source: Human, 2019-2030, $ bn 43
Figure 15. Europe Monoclonal Antibodies Market by Source: Humanized, 2019-2030, $ bn 44
Figure 16. Europe Monoclonal Antibodies Market by Source: Chimeric, 2019-2030, $ bn 45
Figure 17. Europe Monoclonal Antibodies Market by Source: Murine, 2019-2030, $ bn 46
Figure 18. Breakdown of Europe Monoclonal Antibodies Market by Category, 2019-2030, % of Sales Revenue 48
Figure 19. Europe Addressable Market Cap in 2021-2030 by Category, Value ($ bn) and Share (%) 48
Figure 20. Europe Monoclonal Antibodies Market by Category: Branded mAbs, 2019-2030, $ bn 49
Figure 21. Europe Monoclonal Antibodies Market by Category: Biosimilar mAbs, 2019-2030, $ bn 50
Figure 22. Breakdown of Europe Monoclonal Antibodies Market by Production Type, 2019-2030, % of Sales Revenue 52
Figure 23. Europe Addressable Market Cap in 2021-2030 by Production Type, Value ($ bn) and Share (%) 52
Figure 24. Europe Monoclonal Antibodies Market by Production Type: In Vitro Production, 2019-2030, $ bn 53
Figure 25. Europe Monoclonal Antibodies Market by Production Type: In Vivo Production, 2019-2030, $ bn 54
Figure 26. Breakdown of Europe Monoclonal Antibodies Market by Application, 2019-2030, % of Revenue 56
Figure 27. Europe Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%) 56
Figure 28. Europe Monoclonal Antibodies Market by Application: Cancer, 2019-2030, $ bn 57
Figure 29. Europe Monoclonal Antibodies Market by Cancer Type: Breast Cancer, 2019-2030, $ bn 59
Figure 30. Europe Monoclonal Antibodies Market by Cancer Type: Colorectal Cancer, 2019-2030, $ bn 60
Figure 31. Europe Monoclonal Antibodies Market by Cancer Type: Lung Cancer, 2019-2030, $ bn 61
Figure 32. Europe Monoclonal Antibodies Market by Cancer Type: Ovarian Cancer, 2019-2030, $ bn 62
Figure 33. Europe Monoclonal Antibodies Market by Cancer Type: Other Cancer Types, 2019-2030, $ bn 63
Figure 34. Europe Monoclonal Antibodies Market by Application: Autoimmune Diseases, 2019-2030, $ bn 64
Figure 35. Europe Monoclonal Antibodies Market by Application: Inflammatory Diseases, 2019-2030, $ bn 65
Figure 36. Europe Monoclonal Antibodies Market by Application: Infectious Diseases, 2019-2030, $ bn 66
Figure 37. Europe Monoclonal Antibodies Market by Application: Other Applications, 2019-2030, $ bn 67
Figure 38. Breakdown of Europe Monoclonal Antibodies Market by End User, 2019-2030, % of Revenue 69
Figure 39. Europe Addressable Market Cap in 2021-2030 by End User, Value ($ bn) and Share (%) 69
Figure 40. Europe Monoclonal Antibodies Market by End User: Hospitals, 2019-2030, $ bn 70
Figure 41. Europe Monoclonal Antibodies Market by End User: Research Institutes, 2019-2030, $ bn 71
Figure 42. Europe Monoclonal Antibodies Market by End User: Other End Users, 2019-2030, $ bn 72
Figure 43. Breakdown of European Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue 74
Figure 44. Contribution to Europe 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 75
Figure 45. Monoclonal Antibodies Market in Germany, 2019-2030, $ bn 76
Figure 46. Monoclonal Antibodies Market in U.K., 2019-2030, $ bn 78
Figure 47. Monoclonal Antibodies Market in France, 2019-2030, $ bn 80
Figure 48. Monoclonal Antibodies Market in Spain, 2019-2030, $ bn 82
Figure 49. Monoclonal Antibodies Market in Italy, 2019-2030, $ bn 84
Figure 50. Monoclonal Antibodies Market in Russia, 2019-2030, $ bn 86
Figure 51. Monoclonal Antibodies Market in Rest of Europe, 2019-2030, $ bn 88
Figure 52. Growth Stage of Europe Monoclonal Antibodies Industry over the Forecast Period 90
